Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 201 entries
Sorted by: Best Match Show Resources per page
Indomethacin-induced gastric ulceration in rats: Protective roles of .

Toxicology reports

Sabiu S, Garuba T, Sunmonu T, Ajani E, Sulyman A, Nurain I, Balogun A.
PMID: 28962358
Toxicol Rep. 2015 Jan 08;2:261-267. doi: 10.1016/j.toxrep.2015.01.002. eCollection 2015.

This study investigated the quantitative polyphenolic constituents and gastroprotective effects of aqueous leaf extracts of

Cite
Sabiu S, Garuba T, Sunmonu T, et al. Indomethacin-induced gastric ulceration in rats: Protective roles of . Toxicol Rep. 2015;2:261-267doi: 10.1016/j.toxrep.2015.01.002.
Sabiu, S., Garuba, T., Sunmonu, T., Ajani, E., Sulyman, A., Nurain, I., & Balogun, A. (2015). Indomethacin-induced gastric ulceration in rats: Protective roles of . Toxicology reports, 2261-267. https://doi.org/10.1016/j.toxrep.2015.01.002
Sabiu, Saheed, et al. "Indomethacin-induced gastric ulceration in rats: Protective roles of ." Toxicology reports vol. 2 (2015): 261-267. doi: https://doi.org/10.1016/j.toxrep.2015.01.002
Sabiu S, Garuba T, Sunmonu T, Ajani E, Sulyman A, Nurain I, Balogun A. Indomethacin-induced gastric ulceration in rats: Protective roles of . Toxicol Rep. 2015 Jan 08;2:261-267. doi: 10.1016/j.toxrep.2015.01.002. eCollection 2015. PMID: 28962358; PMCID: PMC5598261.
Copy Download .nbib Format: NLM
From Green Space to Green Prescriptions: Challenges and Opportunities for Research and Practice.

Frontiers in psychology

Van den Berg AE.
PMID: 28289398
Front Psychol. 2017 Feb 27;8:268. doi: 10.3389/fpsyg.2017.00268. eCollection 2017.

No abstract available.

Cite
Van den Berg AE. From Green Space to Green Prescriptions: Challenges and Opportunities for Research and Practice. Front Psychol. 2017;8:268doi: 10.3389/fpsyg.2017.00268.
Van den Berg, A. E. (2017). From Green Space to Green Prescriptions: Challenges and Opportunities for Research and Practice. Frontiers in psychology, 8268. https://doi.org/10.3389/fpsyg.2017.00268
Van den Berg, Agnes E. "From Green Space to Green Prescriptions: Challenges and Opportunities for Research and Practice." Frontiers in psychology vol. 8 (2017): 268. doi: https://doi.org/10.3389/fpsyg.2017.00268
Van den Berg AE. From Green Space to Green Prescriptions: Challenges and Opportunities for Research and Practice. Front Psychol. 2017 Feb 27;8:268. doi: 10.3389/fpsyg.2017.00268. eCollection 2017. PMID: 28289398; PMCID: PMC5326776.
Copy Download .nbib Format: NLM
Editorial: A Revised Approach to the Pathogenesis and Diagnosis of Myelodysplastic Syndromes With Therapeutic Implications.

Frontiers in oncology

Aanei CM, Campos Catafal L, Guyotat D.
PMID: 30079311
Front Oncol. 2018 Jul 17;8:261. doi: 10.3389/fonc.2018.00261. eCollection 2018.

No abstract available.

Cite
Aanei CM, Campos Catafal L, Guyotat D. Editorial: A Revised Approach to the Pathogenesis and Diagnosis of Myelodysplastic Syndromes With Therapeutic Implications. Front Oncol. 2018;8:261doi: 10.3389/fonc.2018.00261.
Aanei, C. M., Campos Catafal, L., & Guyotat, D. (2018). Editorial: A Revised Approach to the Pathogenesis and Diagnosis of Myelodysplastic Syndromes With Therapeutic Implications. Frontiers in oncology, 8261. https://doi.org/10.3389/fonc.2018.00261
Aanei, Carmen Mariana, et al. "Editorial: A Revised Approach to the Pathogenesis and Diagnosis of Myelodysplastic Syndromes With Therapeutic Implications." Frontiers in oncology vol. 8 (2018): 261. doi: https://doi.org/10.3389/fonc.2018.00261
Aanei CM, Campos Catafal L, Guyotat D. Editorial: A Revised Approach to the Pathogenesis and Diagnosis of Myelodysplastic Syndromes With Therapeutic Implications. Front Oncol. 2018 Jul 17;8:261. doi: 10.3389/fonc.2018.00261. eCollection 2018. PMID: 30079311; PMCID: PMC6063204.
Copy Download .nbib Format: NLM
An Ophthalmic Insight into Novel Coronavirus 2019 Disease: A Comprehensive Review of the Ocular Manifestations and Clinical Hazards.

Journal of current ophthalmology

Badawi AE, Elsheikh SS, Addeen SZ, Soliman MA, Abd-Rabu R, Abdella WS, Gad EA.
PMID: 33553832
J Curr Ophthalmol. 2020 Dec 12;32(4):315-328. doi: 10.4103/JOCO.JOCO_255_20. eCollection 2020.

PURPOSE: To discuss the ocular manifestations provoked by novel coronavirus 2019 (COVID-19) disease in humans, the natural history of the disease in the eye, and its treatment.METHODS: We designed a narrative review of the ocular manifestations of COVID-19 based...

Cite
Badawi AE, Elsheikh SS, Addeen SZ, et al. An Ophthalmic Insight into Novel Coronavirus 2019 Disease: A Comprehensive Review of the Ocular Manifestations and Clinical Hazards. J Curr Ophthalmol. 2020;32(4):315-328doi: 10.4103/JOCO.JOCO_255_20.
Badawi, A. E., Elsheikh, S. S., Addeen, S. Z., Soliman, M. A., Abd-Rabu, R., Abdella, W. S., & Gad, E. A. (2020). An Ophthalmic Insight into Novel Coronavirus 2019 Disease: A Comprehensive Review of the Ocular Manifestations and Clinical Hazards. Journal of current ophthalmology, 32(4), 315-328. https://doi.org/10.4103/JOCO.JOCO_255_20
Badawi, Amani E, et al. "An Ophthalmic Insight into Novel Coronavirus 2019 Disease: A Comprehensive Review of the Ocular Manifestations and Clinical Hazards." Journal of current ophthalmology vol. 32,4 (2020): 315-328. doi: https://doi.org/10.4103/JOCO.JOCO_255_20
Badawi AE, Elsheikh SS, Addeen SZ, Soliman MA, Abd-Rabu R, Abdella WS, Gad EA. An Ophthalmic Insight into Novel Coronavirus 2019 Disease: A Comprehensive Review of the Ocular Manifestations and Clinical Hazards. J Curr Ophthalmol. 2020 Dec 12;32(4):315-328. doi: 10.4103/JOCO.JOCO_255_20. eCollection 2020. PMID: 33553832; PMCID: PMC7861109.
Copy Download .nbib Format: NLM
Ameliorative effects of hexane extract of .

Drug and chemical toxicology

Folayan A, Akani E, Adebayo OA, Akanni OO, Owumi SE, Tijani AS, Adaramoye OA.
PMID: 32811196
Drug Chem Toxicol. 2020 Aug 18;1-11. doi: 10.1080/01480545.2020.1808671. Epub 2020 Aug 18.

No abstract available.

Cite
Folayan A, Akani E, Adebayo OA, et al. Ameliorative effects of hexane extract of . Drug Chem Toxicol. 2020;1-11doi: 10.1080/01480545.2020.1808671.
Folayan, A., Akani, E., Adebayo, O. A., Akanni, O. O., Owumi, S. E., Tijani, A. S., & Adaramoye, O. A. (2020). Ameliorative effects of hexane extract of . Drug and chemical toxicology, 1-11. https://doi.org/10.1080/01480545.2020.1808671
Folayan, Adeniyi, et al. "Ameliorative effects of hexane extract of ." Drug and chemical toxicology vol. (2020): 1-11. doi: https://doi.org/10.1080/01480545.2020.1808671
Folayan A, Akani E, Adebayo OA, Akanni OO, Owumi SE, Tijani AS, Adaramoye OA. Ameliorative effects of hexane extract of . Drug Chem Toxicol. 2020 Aug 18;1-11. doi: 10.1080/01480545.2020.1808671. Epub 2020 Aug 18. PMID: 32811196.
Copy Download .nbib Format: NLM
Prostate-specific loss of UXT promotes cancer progression.

Oncotarget

Wang Y, Schafler ED, Thomas PA, Ha S, David G, Adney E, Garabedian MJ, Lee P, Logan SK.
PMID: 30774773
Oncotarget. 2019 Jan 22;10(7):707-716. doi: 10.18632/oncotarget.26573. eCollection 2019 Jan 22.

Ubiquitously-expressed, prefoldin-like chaperone (UXT) also called Androgen Receptor Trapped clone-27 (ART-27) is widely expressed in human tissues. Our previous studies showed that UXT regulates transcription repression including androgen receptor (AR) signaling in prostate cancer. Here we analyzed a tissue...

Cite
Wang Y, Schafler ED, Thomas PA, et al. Prostate-specific loss of UXT promotes cancer progression. Oncotarget. 2019;10(7):707-716doi: 10.18632/oncotarget.26573.
Wang, Y., Schafler, E. D., Thomas, P. A., Ha, S., David, G., Adney, E., Garabedian, M. J., Lee, P., & Logan, S. K. (2019). Prostate-specific loss of UXT promotes cancer progression. Oncotarget, 10(7), 707-716. https://doi.org/10.18632/oncotarget.26573
Wang, Yu, et al. "Prostate-specific loss of UXT promotes cancer progression." Oncotarget vol. 10,7 (2019): 707-716. doi: https://doi.org/10.18632/oncotarget.26573
Wang Y, Schafler ED, Thomas PA, Ha S, David G, Adney E, Garabedian MJ, Lee P, Logan SK. Prostate-specific loss of UXT promotes cancer progression. Oncotarget. 2019 Jan 22;10(7):707-716. doi: 10.18632/oncotarget.26573. eCollection 2019 Jan 22. PMID: 30774773; PMCID: PMC6366831.
Copy Download .nbib Format: NLM
The epidemiology is promising, but the trial evidence is weak. Why pharmacological dementia risk reduction trials haven't lived up to expectations, and where do we go from here?.

Alzheimer's & dementia : the journal of the Alzheimer's Association

Peters R, Dodge HH, James S, Jicha GA, Meyer PF, Richards M, Smith AD, Yassine HN, Abner E, Hainsworth AH, Kehoe PG, Beckett N, Anderson CS, Anstey KJ.
PMID: 34726352
Alzheimers Dement. 2021 Nov 02; doi: 10.1002/alz.12393. Epub 2021 Nov 02.

There is an urgent need for interventions that can prevent or delay cognitive decline and dementia. Decades of epidemiological research have identified potential pharmacological strategies for risk factor modification to prevent these serious conditions, but clinical trials have failed...

Cite
Peters R, Dodge HH, James S, et al. The epidemiology is promising, but the trial evidence is weak. Why pharmacological dementia risk reduction trials haven't lived up to expectations, and where do we go from here?. Alzheimers Dement. 2021;doi: 10.1002/alz.12393.
Peters, R., Dodge, H. H., James, S., Jicha, G. A., Meyer, P. F., Richards, M., Smith, A. D., Yassine, H. N., Abner, E., Hainsworth, A. H., Kehoe, P. G., Beckett, N., Anderson, C. S., & Anstey, K. J. (2021). The epidemiology is promising, but the trial evidence is weak. Why pharmacological dementia risk reduction trials haven't lived up to expectations, and where do we go from here?. Alzheimer's & dementia : the journal of the Alzheimer's Association, . https://doi.org/10.1002/alz.12393
Peters, Ruth, et al. "The epidemiology is promising, but the trial evidence is weak. Why pharmacological dementia risk reduction trials haven't lived up to expectations, and where do we go from here?." Alzheimer's & dementia : the journal of the Alzheimer's Association vol. (2021). doi: https://doi.org/10.1002/alz.12393
Peters R, Dodge HH, James S, Jicha GA, Meyer PF, Richards M, Smith AD, Yassine HN, Abner E, Hainsworth AH, Kehoe PG, Beckett N, Anderson CS, Anstey KJ. The epidemiology is promising, but the trial evidence is weak. Why pharmacological dementia risk reduction trials haven't lived up to expectations, and where do we go from here?. Alzheimers Dement. 2021 Nov 02; doi: 10.1002/alz.12393. Epub 2021 Nov 02. PMID: 34726352.
Copy Download .nbib Format: NLM
Ergonomic Analysis of Functional Endoscopic Sinus Surgery Using Novel Inertial Sensors.

The Laryngoscope

Arrighi-Allisan AE, Garvey KL, Wong A, Filip P, Shah J, Spock T, Del Signore A, Cosetti MK, Govindaraj S, Iloreta AM.
PMID: 34355793
Laryngoscope. 2021 Aug 06; doi: 10.1002/lary.29796. Epub 2021 Aug 06.

OBJECTIVES/HYPOTHESIS: Suboptimal ergonomics during endoscopic sinus surgery can lead to considerable physical discomfort and fatigue for the surgeon. The purpose of this pilot study is to objectively evaluate the ergonomic positions of trainee and attending surgeons while performing functional...

Cite
Arrighi-Allisan AE, Garvey KL, Wong A, et al. Ergonomic Analysis of Functional Endoscopic Sinus Surgery Using Novel Inertial Sensors. Laryngoscope. 2021;doi: 10.1002/lary.29796.
Arrighi-Allisan, A. E., Garvey, K. L., Wong, A., Filip, P., Shah, J., Spock, T., Del Signore, A., Cosetti, M. K., Govindaraj, S., & Iloreta, A. M. (2021). Ergonomic Analysis of Functional Endoscopic Sinus Surgery Using Novel Inertial Sensors. The Laryngoscope, . https://doi.org/10.1002/lary.29796
Arrighi-Allisan, Annie E, et al. "Ergonomic Analysis of Functional Endoscopic Sinus Surgery Using Novel Inertial Sensors." The Laryngoscope vol. (2021). doi: https://doi.org/10.1002/lary.29796
Arrighi-Allisan AE, Garvey KL, Wong A, Filip P, Shah J, Spock T, Del Signore A, Cosetti MK, Govindaraj S, Iloreta AM. Ergonomic Analysis of Functional Endoscopic Sinus Surgery Using Novel Inertial Sensors. Laryngoscope. 2021 Aug 06; doi: 10.1002/lary.29796. Epub 2021 Aug 06. PMID: 34355793.
Copy Download .nbib Format: NLM
Electronic health record-based genome-wide meta-analysis provides insights on the genetic architecture of non-alcoholic fatty liver disease.

Cell reports. Medicine

Ghodsian N, Abner E, Emdin CA, Gobeil É, Taba N, Haas ME, Perrot N, Manikpurage HD, Gagnon É, Bourgault J, St-Amand A, Couture C, Mitchell PL, Bossé Y, Mathieu P, Vohl MC, Tchernof A, Thériault S, Khera AV, Esko T, Arsenault BJ.
PMID: 34841290
Cell Rep Med. 2021 Nov 03;2(11):100437. doi: 10.1016/j.xcrm.2021.100437. eCollection 2021 Nov 16.

Non-alcoholic fatty liver disease (NAFLD) is a complex disease linked to several chronic diseases. We aimed at identifying genetic variants associated with NAFLD and evaluating their functional consequences. We performed a genome-wide meta-analysis of 4 cohorts of electronic health...

Cite
Ghodsian N, Abner E, Emdin CA, et al. Electronic health record-based genome-wide meta-analysis provides insights on the genetic architecture of non-alcoholic fatty liver disease. Cell Rep Med. 2021;2(11):100437doi: 10.1016/j.xcrm.2021.100437.
Ghodsian, N., Abner, E., Emdin, C. A., Gobeil, �. �., Taba, N., Haas, M. E., Perrot, N., Manikpurage, H. D., Gagnon, �. �., Bourgault, J., St-Amand, A., Couture, C., Mitchell, P. L., Bossé, Y., Mathieu, P., Vohl, M. C., Tchernof, A., Thériault, S., Khera, A. V., Esko, T., & Arsenault, B. J. (2021). Electronic health record-based genome-wide meta-analysis provides insights on the genetic architecture of non-alcoholic fatty liver disease. Cell reports. Medicine, 2(11), 100437. https://doi.org/10.1016/j.xcrm.2021.100437
Ghodsian, Nooshin, et al. "Electronic health record-based genome-wide meta-analysis provides insights on the genetic architecture of non-alcoholic fatty liver disease." Cell reports. Medicine vol. 2,11 (2021): 100437. doi: https://doi.org/10.1016/j.xcrm.2021.100437
Ghodsian N, Abner E, Emdin CA, Gobeil É, Taba N, Haas ME, Perrot N, Manikpurage HD, Gagnon É, Bourgault J, St-Amand A, Couture C, Mitchell PL, Bossé Y, Mathieu P, Vohl MC, Tchernof A, Thériault S, Khera AV, Esko T, Arsenault BJ. Electronic health record-based genome-wide meta-analysis provides insights on the genetic architecture of non-alcoholic fatty liver disease. Cell Rep Med. 2021 Nov 03;2(11):100437. doi: 10.1016/j.xcrm.2021.100437. eCollection 2021 Nov 16. PMID: 34841290; PMCID: PMC8606899.
Copy Download .nbib Format: NLM
Multi-tasking community-based bilingual doulas are bridging gaps-Despite standing on fragile ground. A qualitative study of doulas' experiences in Sweden.

Midwifery

Helena L, Amani E, Anna W, Nataliia T, Rhonda S, Erica S.
PMID: 34979361
Midwifery. 2021 Dec 25;105:103231. doi: 10.1016/j.midw.2021.103231. Epub 2021 Dec 25.

INTRODUCTION: Community-based Bilingual Doulas (CBDs) are women from migrant communities trained to support and comfort migrant women during labour and birth, and to facilitate linguistic and cultural communication between women, their partners and staff. The aim of the study...

Cite
Helena L, Amani E, Anna W, et al. Multi-tasking community-based bilingual doulas are bridging gaps-Despite standing on fragile ground. A qualitative study of doulas' experiences in Sweden. Midwifery. 2021;105:103231doi: 10.1016/j.midw.2021.103231.
Helena, L., Amani, E., Anna, W., Nataliia, T., Rhonda, S., & Erica, S. (2021). Multi-tasking community-based bilingual doulas are bridging gaps-Despite standing on fragile ground. A qualitative study of doulas' experiences in Sweden. Midwifery, 105103231. https://doi.org/10.1016/j.midw.2021.103231
Helena, Lindgren, et al. "Multi-tasking community-based bilingual doulas are bridging gaps-Despite standing on fragile ground. A qualitative study of doulas' experiences in Sweden." Midwifery vol. 105 (2021): 103231. doi: https://doi.org/10.1016/j.midw.2021.103231
Helena L, Amani E, Anna W, Nataliia T, Rhonda S, Erica S. Multi-tasking community-based bilingual doulas are bridging gaps-Despite standing on fragile ground. A qualitative study of doulas' experiences in Sweden. Midwifery. 2021 Dec 25;105:103231. doi: 10.1016/j.midw.2021.103231. Epub 2021 Dec 25. PMID: 34979361.
Copy Download .nbib Format: NLM
Dementia risk reduction: why haven't the pharmacological risk reduction trials worked? An in-depth exploration of seven established risk factors.

Alzheimer's & dementia (New York, N. Y.)

Peters R, Breitner J, James S, Jicha GA, Meyer PF, Richards M, Smith AD, Yassine HN, Abner E, Hainsworth AH, Kehoe PG, Beckett N, Weber C, Anderson C, Anstey KJ, Dodge HH.
PMID: 34934803
Alzheimers Dement (N Y). 2021 Dec 08;7(1):e12202. doi: 10.1002/trc2.12202. eCollection 2021.

Identifying the leading health and lifestyle factors for the risk of incident dementia and Alzheimer's disease has yet to translate to risk reduction. To understand why, we examined the discrepancies between observational and clinical trial evidence for seven modifiable...

Cite
Peters R, Breitner J, James S, et al. Dementia risk reduction: why haven't the pharmacological risk reduction trials worked? An in-depth exploration of seven established risk factors. Alzheimers Dement (N Y). 2021;7(1):e12202doi: 10.1002/trc2.12202.
Peters, R., Breitner, J., James, S., Jicha, G. A., Meyer, P. F., Richards, M., Smith, A. D., Yassine, H. N., Abner, E., Hainsworth, A. H., Kehoe, P. G., Beckett, N., Weber, C., Anderson, C., Anstey, K. J., & Dodge, H. H. (2021). Dementia risk reduction: why haven't the pharmacological risk reduction trials worked? An in-depth exploration of seven established risk factors. Alzheimer's & dementia (New York, N. Y.), 7(1), e12202. https://doi.org/10.1002/trc2.12202
Peters, Ruth, et al. "Dementia risk reduction: why haven't the pharmacological risk reduction trials worked? An in-depth exploration of seven established risk factors." Alzheimer's & dementia (New York, N. Y.) vol. 7,1 (2021): e12202. doi: https://doi.org/10.1002/trc2.12202
Peters R, Breitner J, James S, Jicha GA, Meyer PF, Richards M, Smith AD, Yassine HN, Abner E, Hainsworth AH, Kehoe PG, Beckett N, Weber C, Anderson C, Anstey KJ, Dodge HH. Dementia risk reduction: why haven't the pharmacological risk reduction trials worked? An in-depth exploration of seven established risk factors. Alzheimers Dement (N Y). 2021 Dec 08;7(1):e12202. doi: 10.1002/trc2.12202. eCollection 2021. PMID: 34934803; PMCID: PMC8655351.
Copy Download .nbib Format: NLM
Strong π-Backbonding Enables Record Magnetic Exchange Coupling Through Cyanide.

Journal of the American Chemical Society

Valdez-Moreira JA, Thorarinsdottir AE, DeGayner JA, Lutz SA, Chen CH, Losovyj Y, Pink M, Harris TD, Smith JM.
PMID: 31601108
J Am Chem Soc. 2019 Oct 30;141(43):17092-17097. doi: 10.1021/jacs.9b09445. Epub 2019 Oct 16.

The paramagnetic cyano-bridged complex PhB(

Cite
Valdez-Moreira JA, Thorarinsdottir AE, DeGayner JA, et al. Strong π-Backbonding Enables Record Magnetic Exchange Coupling Through Cyanide. J Am Chem Soc. 2019;141(43):17092-17097doi: 10.1021/jacs.9b09445.
Valdez-Moreira, J. A., Thorarinsdottir, A. E., DeGayner, J. A., Lutz, S. A., Chen, C. H., Losovyj, Y., Pink, M., Harris, T. D., & Smith, J. M. (2019). Strong π-Backbonding Enables Record Magnetic Exchange Coupling Through Cyanide. Journal of the American Chemical Society, 141(43), 17092-17097. https://doi.org/10.1021/jacs.9b09445
Valdez-Moreira, Juan A, et al. "Strong π-Backbonding Enables Record Magnetic Exchange Coupling Through Cyanide." Journal of the American Chemical Society vol. 141,43 (2019): 17092-17097. doi: https://doi.org/10.1021/jacs.9b09445
Valdez-Moreira JA, Thorarinsdottir AE, DeGayner JA, Lutz SA, Chen CH, Losovyj Y, Pink M, Harris TD, Smith JM. Strong π-Backbonding Enables Record Magnetic Exchange Coupling Through Cyanide. J Am Chem Soc. 2019 Oct 30;141(43):17092-17097. doi: 10.1021/jacs.9b09445. Epub 2019 Oct 16. PMID: 31601108.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 201 entries